New research published in the December 2014 issue of the Journal of Leukocyte Biology , shows that a component found in in the plant, Glycyrrhiza uralensis , may inhibit the development of metabolic disorders by stopping the activation of NLRP3, a protein involved in the disease process. Specifically, the researchers identified isoliquiritigenin as having the ability to attenuate high-fat, diet-induced obesity, type 2 diabetes and hepatic steatosis in mice.
http://ift.tt/1rOhB9G
http://ift.tt/1rOhB9G
No comments:
Post a Comment